A novel biomarker, active whole skeletal total lesion glycolysis (WS-TLG), as a quantitative method to measure bone metastatic activity in breast cancer patients
نویسندگان
چکیده
منابع مشابه
A Novel Method for Skin Lesion Segmentation
Skin cancer has been the most usual and illustrates 50% of all new cancers detected each year. If they detected at an early stage, treatment can become simple and economically. Accurate skin lesion segmentation is important in automated early skin cancer detection and diagnosis systems. The aim of this study is to provide an effective approach to detect the skin lesion border on a purposed imag...
متن کاملA Novel Method for Skin Lesion Segmentation
Skin cancer has been the most usual and illustrates 50% of all new cancers detected each year. If they detected at an early stage, treatment can become simple and economically. Accurate skin lesion segmentation is important in automated early skin cancer detection and diagnosis systems. The aim of this study is to provide an effective approach to detect the skin lesion border on a purposed imag...
متن کاملMetastatic carcinoid presenting as a breast lesion.
Metastasis to the breast is a rare occurrence, constituting fewer than 2% of all breast tumours. Of all metastatic tumours in the breast, most arise from contralateral breast primaries. Other reported primary solid tumour sites include melanoma; lung, gastric, and renal cancers; and approximately 29 cases of carcinoid tumour.Ambiguous presentations and an absence of carcinoid syndrome features ...
متن کاملQuantitative bone scan lesion area as an early surrogate outcome measure indicative of overall survival in metastatic prostate cancer.
A clinical validation of the bone scan lesion area (BSLA) as a quantitative imaging biomarker was performed in metastatic castration-resistant prostate cancer (mCRPC). BSLA was computed from whole-body bone scintigraphy at baseline and week 12 posttreatment in a cohort of 198 mCRPC subjects (127 treated and 71 placebo) from a clinical trial involving a different drug from the initial biomarker ...
متن کاملAutomated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide
BACKGROUND Having performed analytical validation studies, we are now assessing the clinical utility of the upgraded automated Bone Scan Index (BSI) in metastatic castration-resistant prostate cancer (mCRPC). In the present study, we retrospectively evaluated the discriminatory strength of the automated BSI in predicting overall survival (OS) in mCRPC patients being treated with enzalutamide. ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Nuclear Medicine
سال: 2019
ISSN: 0914-7187,1864-6433
DOI: 10.1007/s12149-019-01359-4